Deborah Fine

A dynamic C-suite commercialization executive and proven CEO, leading 6 diverse B2B and B2C businesses to record growth and profit in both public and private companies, ranging from start up to $1 billion in revenue. Industry experience includes healthcare, consumer products, retail via direct to consumer and wholesale channels, and media. An innovative leader consistently able to drive growth in start up environments as well as large, matrixed organizations. Strong track record of attracting and retaining top talent to develop results-driven executive teams.

Exceptional communicator who formulates highly resonant messaging resulting in scaled adoption of new products, services, technologies, and business models. Deep expertise and a novel approach to building impactful strategic alliances of scale across key stakeholder groups and industry sectors, most recently with healthcare Key Opinion Leaders from hospital systems, academic medical institutions, physician chairs, government agencies, employer networks, patient advocacy groups, professional organizations, government and commercial payers, financial institutions, and biotech service providers.

Current member of 8 boards and councils, primarily focused on digital health, biotechnology, and ESG, including Laguna Health, Springboard Enterprise Life Sciences Council, The United Nations Development Programme, MIT ReACT, and Harvard Women’s Leadership Board.

Pamela Gill is a healthcare and not-for-profit consultant who brings experience as a clinical provider who has served in multiple executive positions, most recently as the President and CEO of Recovery Resources, a comprehensive non-profit behavioral health care organization where she led the acquisition of the agency by a major academic medical Center. Pam has had an extensive career in hospital and healthcare administration including leadership positions at The Cleveland Clinic, a global healthcare organization. Pam is a registered nurse; her clinical background is in neurosciences and her areas of interest are strategic planning and population health management. Pam has keen interest in innovative solutions through both technology, business partnerships and systems organization. Pam’s career has included strategic experience in multiple health system mergers and acquisitions

A Cleveland, Ohio native, she holds a nursing degree, a bachelor’s degree in Health Care Administration and a master’s degree in biomedical ethics. She is passionate about the arts and community development serving on multiple boards.

Dr. Pronovost is a world-renowned patient safety champion, innovator, critical care physician, researcher (publishing over 1000 peer review publications), entrepreneur (founding two health care startups that were acquired), and a global thought leader, informing US and global health policy. His scientific work leveraging checklists to reduce catheter-related bloodstream infections has saved thousands of lives and earned him high-profile accolades, including being named one of the 100 most influential people in the world by Time Magazine, receiving a coveted MacArthur Foundation “genius grant” in 2008.

Dr. Pronovost currently serves as University Health’s Chief Quality & Clinical Transformation Officer, a role in which he is charged with fostering ideation and implementation for new protocols to eliminate defects in value and thereby enhance quality of care. Previously, Dr. Pronovost served as the Senior Vice President for Patient Safety and Quality at Johns Hopkins Medicine as well as the founder and director of the Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality. In this role, he worked to eliminate all harms in one health system following on his success in eliminating one harm in most health systems across the U.S. Dr. Pronovost also served as the Senior Vice President for Clinical Strategy and the Chief Medical officer for UnitedHealthcare.

Dr. Di Capua is a board certified internist with a business background and formal training in health services research.  He studied neurobiology at Harvard University, then went to Yale University for a joint degree, MD, MBA. He trained in internal medicine at Stanford and UCLA. He is interested in designing healthcare systems for its users (patients, caregivers, physicians, and other health professionals) by using data, design principles, and organizational behavior. He is the Regional Medical Officer for Caremore Health in Connecticut, where is leading the implementation of a program in home-based primary care.

Dr. Avi Tsur, M.D is the Founder and Director of the Sheba Women’s Health Innovation Center, a collaborative effort or ARC, the Sheba Department of Obstetrics & Gynecology and the Gertner Institute for Health Policy and Epidemiology.

Serves as Head of the Sheba Beyond Women’s Health Telemedicine Services providing cutting edge remote healthcare services across Israel and Beyond.

Clinically trained in the Hadassah Medical School, Sheba Medical Center and Stanford University Medical Center, and clinically serves as attending physician at the Sheba Antepartum (high-risk pregnancy) Department, High-risk Pregnancy Clinics and the Obstetrics and Gynecology Ultrasound Unit.

Leading a National Ministry of Health Committee, promoting telemedicine in women’s healthcare.

Dr. Tsur holds patents for several predictive machine learning models in the field of Obstetrics and Gynecology, is the founder of BirthAI.org and was the lead medical inventor of the Lioness, a mechanical device for prevention of preterm birth currently commercialized by Pregnantech.

Serves as principal investigator of several cutting edge studies –  PTBiome, precision gestational diabetes, and remote postdate fetal monitoring.  Author of 35 peer reviewed manuscripts and three book chapters.

Mentor at Biodesign Israel and the and at the Interdisciplinary Center Herzliya (IDC) program in Healthcare Innovation.